JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC CO., LTD. Financials JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
Equities
JSP
THA520010002
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.6 THB | +1.56% |
|
-4.41% | +13.04% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 3,367 | 1,647 | 1,091 |
| Enterprise Value (EV) 1 | 2,900 | 1,502 | 1,361 |
| P/E ratio | 89.8 x | -90.5 x | -851 x |
| Yield | 0.18% | - | - |
| Capitalization / Revenue | 7.85 x | 3.77 x | 1.84 x |
| EV / Revenue | 6.76 x | 3.44 x | 2.29 x |
| EV / EBITDA | 46.4 x | 748 x | 39.9 x |
| EV / FCF | -565 x | -4.96 x | -8.02 x |
| FCF Yield | -0.18% | -20.2% | -12.5% |
| Price to Book | 3.48 x | 1.75 x | 1.25 x |
| Nbr of stocks (in thousands) | 455,000 | 455,000 | 474,555 |
| Reference price 2 | 7.400 | 3.620 | 2.300 |
| Announcement Date | 2/28/22 | 2/28/23 | 2/29/24 |
1THB in Million2THB
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 352.2 | 369.3 | 462.7 | 429.1 | 436.5 | 594.4 |
| EBITDA 1 | 43.31 | 58.53 | 68.99 | 62.42 | 2.008 | 34.1 |
| EBIT 1 | 30.21 | 42.93 | 53.12 | 47.83 | -15.06 | 0.6583 |
| Operating Margin | 8.58% | 11.62% | 11.48% | 11.15% | -3.45% | 0.11% |
| Earnings before Tax (EBT) 1 | 16.87 | 30.09 | 39.68 | 37.43 | -21.44 | 6.51 |
| Net income 1 | 12.39 | 23.57 | 31.08 | 29.69 | -17.48 | -1.269 |
| Net margin | 3.52% | 6.38% | 6.72% | 6.92% | -4.01% | -0.21% |
| EPS 2 | 0.0562 | 0.0816 | 0.0927 | 0.0824 | -0.0400 | -0.002704 |
| Free Cash Flow 1 | -53.18 | 1.769 | 16.22 | -5.13 | -302.6 | -169.8 |
| FCF margin | -15.1% | 0.48% | 3.5% | -1.2% | -69.33% | -28.57% |
| FCF Conversion (EBITDA) | - | 3.02% | 23.51% | - | - | - |
| FCF Conversion (Net income) | - | 7.51% | 52.18% | - | - | - |
| Dividend per Share | - | - | - | 0.0132 | - | - |
| Announcement Date | 4/23/21 | 4/23/21 | 4/23/21 | 2/28/22 | 2/28/23 | 2/29/24 |
1THB in Million2THB
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 238 | 198 | 209 | - | - | 270 |
| Net Cash position 1 | - | - | - | 467 | 146 | - |
| Leverage (Debt/EBITDA) | 5.493 x | 3.384 x | 3.03 x | - | - | 7.914 x |
| Free Cash Flow 1 | -53.2 | 1.77 | 16.2 | -5.13 | -303 | -170 |
| ROE (net income / shareholders' equity) | 13.6% | 17.1% | 17.2% | 5.11% | -1.83% | -0.28% |
| ROA (Net income/ Total Assets) | 4.6% | 6.11% | 7.17% | 3.43% | -0.76% | 0.03% |
| Assets 1 | 269.4 | 385.5 | 433.5 | 866.4 | 2,307 | -4,174 |
| Book Value Per Share 2 | 0.4300 | 0.5200 | 0.5800 | 2.120 | 2.070 | 1.830 |
| Cash Flow per Share 2 | 0 | 0 | 0 | 1.370 | 0.2100 | 0.0400 |
| Capex 1 | 52.2 | 17 | 7.15 | 36.5 | 289 | 173 |
| Capex / Sales | 14.82% | 4.6% | 1.54% | 8.52% | 66.11% | 29.09% |
| Announcement Date | 4/23/21 | 4/23/21 | 4/23/21 | 2/28/22 | 2/28/23 | 2/29/24 |
1THB in Million2THB
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +13.04% | 33.57M | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
- Stock Market
- Equities
- JSP Stock
- Financials JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.
